3-氯邻苯二胺 | 21745-41-5

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-氯邻苯二胺
• 中文别名: 3-氯-1,2-苯二胺
• 英文名称: 2,3-diaminochlorobenzene
• 英文别名: 3-chlorobenzene-1,2-diamine；1,2-diamino-3-chlorobenzene；3-chloro-o-phenylenediamine；3-chloro-1,2-diaminobenzene；1,2-Diamino-3-chlorbenzol；3-chloro-1,2-phenylenediamine
• CAS: 21745-41-5
• 化学式: C₆H₇ClN₂
• mdl: MFCD09881742
• 分子量: 142.588
• InChiKey: SAIXZIVDXDTYCH-UHFFFAOYSA-N

物化性质

• 沸点：
  125 °C
• 密度：
  1.345±0.06 g/cm3(Predicted)
• 溶解度：
  SMSO（微溶）、甲醇（微溶）

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  52
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2921590090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  2~8℃

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Chlorobenzene-1,2-diamine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Chlorobenzene-1,2-diamine
CAS number: 21745-41-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H7ClN2
Molecular weight: 142.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-氯邻苯二胺 在 N-亚磺酰苯胺 作用下， 以 甲苯 为溶剂， 反应 5.0h， 以93%的产率得到4-氯-2,1,3-苯并噻二唑
  参考文献：
  名称：

  荧光二芳基磺酰脲类似物作为 NLRP3 抑制剂和成像探针的合成和药理学验证

  摘要：

  NOD 样受体家族含有 pyrin 结构域的蛋白 3 (NLRP3) 是一种关键的细胞溶质模式识别受体，可感知多种病原体和宿主来源的威胁信号。NLRP3炎性体的异常激活与各种复杂炎性疾病的发病机制密切相关。然而，NLRP3炎症小体的详细调控机制及其在炎症进展中的致病作用仍有待充分阐明。使用小分子探针的荧光成像可以提供有关靶蛋白表达、占有率和生物分布的有价值的可视化信息。在此，我们报道了一系列带有氨基苯并二唑荧光团的二芳基磺酰脲 NLRP3 荧光抑制剂。与之前报道的 NLRP3 荧光探针相比，由于没有通过接头额外附加荧光团，这些抑制剂在结构上更简洁且具有膜渗透性。在这个系列中，复合图13a表现出最强的细胞NLRP3抑制作用，IC 50值为49 nM，并以剂量​​依赖性方式显着抑制LPS/尼日利亚菌素诱导的活性caspase-1和成熟IL-1β的分泌，从而阻断NLRP3的活化炎症小体。同时，这

  DOI：

  10.1016/j.ejmech.2022.114338
• 作为产物：
  描述：

  5-溴-2-硝基苯胺 在 四(三苯基膦)钯 、 palladium on activated charcoal 、 甲酸铵 、 potassium carbonate 作用下， 生成 3-氯邻苯二胺
  参考文献：
  名称：

  Identification of novel HDAC inhibitors through cell based screening and their evaluation as potential anticancer agents

  摘要：

  A series of benzimidazole based HDAC inhibitors have been rationally designed, synthesized and screened. The SAR of this new chemotype is described. The lead compound, 11e, showed strong activity in several cellular assays and demonstrated in vivo efficacy in mouse xenograft pancreatic cancer models. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.07.001
• 作为试剂：
  描述：

  2-氯-6-硝基苯胺 在 钯 3-氯邻苯二胺 作用下， 以 甲醇 为溶剂， 25.0 ℃ 、533.29 MPa 条件下， 生成 3-氯邻苯二胺
  参考文献：
  名称：

  JAK-2 Modulators and Methods of Use

  摘要：

  本发明涉及蛋白酪氨酸激酶及其抑制剂领域。具体而言，本发明涉及JAK-2的抑制剂，以及用于抑制JAK-2的化合物的制药组合物，包括通过将含有本发明化合物的化合物或制药组合物与需要抑制JAK-2的细胞接触来抑制JAK-2的细胞方法。本发明还包括治疗涉及JAK-2的疾病或病状的方法，包括向患者施用包含本发明化合物的制药组合物。

  公开号：

  US20100136136A1

文献信息

• Transition-metal and oxidant-free approach for the synthesis of diverse N-heterocycles by TMSCl activation of isocyanides
  作者：Liangliang Luo、Hongyan Li、Jinxin Liu、Yuan Zhou、Lin Dong、You-Cai Xiao、Fen-Er Chen

  DOI：10.1039/d0ra04636a

  日期：——

  A highly efficient TMSCl-mediated addition of N-nucleophiles to isocyanides has been achieved.

  一种高效的TMSCl介导的N-亲核试剂加成到异氰酸酯的方法已经实现。
• Gold nanoparticles anchored onto the magnetic poly(ionic-liquid) polymer as robust and recoverable catalyst for reduction of Nitroarenes
  作者：Firouz Matloubi Moghaddam、Seyed Ebrahim Ayati、Hamid Reza Firouzi、Seyed Hassan Hosseini、Ali Pourjavadi

  DOI：10.1002/aoc.3825

  日期：2017.12

  Gold nanoparticles supported on poly ionic‐liquid magnetic nanoparticles (MNP@PIL@Au) were synthesized by reduction of HAuCl4 with sodium borohydride. The synthesized catalyst was characterized using by AAS, TEM, FT‐IR, EDS, TGA and XRD techniques. The performance of the synthesized catalyst was investigated in the reduction of nitroarenes with NaBH4. The reaction was carried out for various nitroarenes

  通过用硼氢化钠还原HAuCl4来合成负载在聚离子液体磁性纳米颗粒（MNP @ PIL @ Au）上的金纳米颗粒。使用AAS，TEM，FT-IR，EDS，TGA和XRD技术对合成的催化剂进行了表征。研究了合成催化剂在NaBH 4还原硝基芳烃方面的性能。该反应是在水中和温和条件下对各种硝基芳烃进行的，产率很高。在其他官能团（例如卤化物和炔烃）存在下，还原硝基的催化剂选择性相当好。催化剂的再循环进行了8次，而其催化活性没有任何明显的损失。
• [EN] PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE PYRAZOLOPYRIDINE POUR LE TRAITEMENT DU CANCER
  申请人：GENENTECH INC

  公开号：WO2017205538A1

  公开（公告）日：2017-11-30

  The present invention relates to a compound formula (I): and to salts thereof, wherein R1, R2X, and Y have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders such as cancer, inflammatory disorders and autoimmune diseases.

  本发明涉及一种化合物公式（I）及其盐，其中R1、R2X和Y具有本文中定义的任何值，以及其组合物和用途。这些化合物可用作CBP和/或EP300的抑制剂。还包括包含公式（I）化合物或其药学上可接受的盐的药物组合物，以及在治疗各种CBP和/或EP300介导的疾病，如癌症、炎症性疾病和自身免疫疾病中使用这些化合物和盐的方法。
• QUINOXALINE-BASED LXR MODULATORS
  申请人：Hu Baihua

  公开号：US20100120778A1

  公开（公告）日：2010-05-13

  Disclosed are quinoxaline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): wherein: each of L 1 and L 2 is, independently, a bond, —O— or —NH—; R 2 is C 6 -C 10 aryl or heteroaryl including 5-10 atoms, each of which is (i) substituted with 1 R 9 , and (ii) optionally further substituted with from 1-4 R e ; and each of R 4 and R 5 is, independently (i) hydrogen; or (ii) halo; or (iii) C 1 -C 6 alkyl or C 1 -C 6 haloalkyl, each of which is optionally substituted with from 1-3 R a ; and R 1 , R 3 , R 6 , R 9 , R a and R e are defined herein. In general, these compounds can be used for treating or preventing one or more diseases, disorders, conditions or symptoms mediated by LXRs.

  公开了基于喹诺克的Liver X受体（LXRs）调节剂及相关方法。这些调节剂包括以下式（I）的化合物： 其中： L1和L2分别独立为键，-O-或-NH-； R2是C6-C10的芳基或杂芳基，包括5-10个原子，每个原子（i）带有1个R9基团，和（ii）可选地带有1-4个Re基团； R4和R5分别独立为（i）氢；（ii）卤素；或（iii）C1-C6的烷基或C1-C6的卤代烷基，每个都可选地带有1-3个Ra基团； 以及R1、R3、R6、R9、Ra和Re都在此定义。 一般来说，这些化合物可用于治疗或预防一个或多个由LXRs介导的疾病、失调、状况或症状。
• 헤테로고리 화합물 및 이를 이용한 유기 발광 소자
  申请人：LT Materials Co.,Ltd. 엘티소재주식회사(120060104982) Corp. No ▼ 110111-3251082BRN ▼104-81-94599

  公开号：KR20170004432A

  公开（公告）日：2017-01-11

  본 출원은 유기 발광 소자의 수명, 효율, 전기 화학적 안정성 및 열적 안정성을 크게 향상시킬 수 있는 헤테로고리 화합물, 및 상기 헤테로고리 화합물이 유기 화합물층에 함유되어 있는 유기 발광 소자를 제공한다.

  本发明提供了一种杂环化合物，能够显著提高有机发光器件的寿命、效率、电化学稳定性和热稳定性，以及含有上述杂环化合物的有机发光器件。